# Editorial prompt for: RESVERATROL

Paste everything below this line into Claude.ai or ChatGPT.
Save the model's JSON response as `resveratrol.json` in this same folder.
When you've collected all responses, run:

    inci-pipeline import-editorial

---

You are an editorial writer for a skincare ingredient database. You are summarizing peer-reviewed evidence for a general audience.

Ingredient: RESVERATROL
Declared functions (from EU CosIng): (unspecified)
Restricted in EU: no
Restricted in US: no

Source abstracts (from PubMed):
PMID: unknown
Title: Resveratrol for cancer therapy: Challenges and future perspectives.
Year: 2021
Abstract: Resveratrol (3,4',5-trihydroxy-trans-stilbene) has been expected to ameliorate cancer and foster breakthroughs in cancer therapy. Despite thousands of preclinical studies on the anticancer activity of resveratrol, little progress has been made in translational research and clinical trials. Most studies have focused on its anticancer effects, cellular mechanisms, and signal transduction pathways in vitro and in vivo. In this review, we aimed to discern the causes that prevent resveratrol from being used in cancer treatment. Among the various limitations, poor pharmacokinetics and low potency seem to be the two main bottlenecks of resveratrol. In addition, resveratrol-induced nephrotoxicity in multiple myeloma patients hinders its further development as an anticancer drug. New insights and strategies have been proposed to accelerate the conversion of resveratrol from bench to bedside. In the interim, the most promising approach is to enhance the bioavailability of resveratrol with new formulations. Alternatively, more potent analogues of resveratrol could be developed to augment its anticancer potency. Given all the gaps mentioned, much work remains to be done. However, if remarkable progress can be made, resveratrol may finally be used for cancer therapy.

PMID: unknown
Title: Resveratrol and Its Effects on the Vascular System.
Year: 2019
Abstract: Resveratrol, the phenolic substance isolated initially from

PMID: unknown
Title: The impact of resveratrol on skin wound healing, scarring, and aging.
Year: 2022
Abstract: Resveratrol is a well-known antioxidant that harbours many health beneficial properties. Multiple studies associated the antioxidant, anti-inflammatory, and cell protective effects of resveratrol. These diverse effects of resveratrol are also potentially involved in cutaneous wound healing, scarring, and (photo-)aging of the skin. Hence, this review highlighted the most relevant studies involving resveratrol in wound healing, scarring, and photo-aging of the skin. A systematic review was performed and the database PubMed was searched for suitable publications. Only original articles in English that investigated the effects of resveratrol in wound healing, scarring, and (photo-)aging of the skin were analysed. The literature search yielded a total of 826 studies, but only 41 studies met the inclusion criteria. The included studies showed promising results that resveratrol might be a feasible treatment approach to support wound healing, counteract excessive scarring, and even prevent photo-aging of the skin. Resveratrol represents an interesting and promising novel therapy regime but to confirm resveratrol-associated effects, more evidence based in vitro and in vivo studies are needed.

PMID: unknown
Title: Analgesic resveratrol?
Year: 2008
Abstract: Resveratrol, a red wine and grape-derived phytoalexin, possesses diverse biochemical and physiological functions that are relevant to human health and disease. The emergent properties of resveratrol have forced us to rethink the biomedical significance of the wine culture. Novel observations point to the hypothesis that intracerebral resveratrol treatment diminishes the sensitivity of rats to pain, and that the said analgesic action of resveratrol is a central mechanism mediated by the inhibition of cycloxygenases I and II. This novel implication of resveratrol and perhaps red wine drinking warrants further studies.

PMID: unknown
Title: Resveratrol cytotoxicity is energy-dependent.
Year: 2019
Abstract: Resveratrol is a phytochemical that may promote health. However, it has also been reported to be a toxic compound. The molecular mechanism by which resveratrol acts remains unclear. The inhibition of the oxidative phosphorylation (OXPHOS) pathway appears to be the molecular mechanism of resveratrol. Taking this into account, we propose that the cytotoxic properties of resveratrol depend on the energy (e.g., carbohydrates, lipids, and proteins) availability in the cells. In this regard, in a condition with low energy accessibility, resveratrol could enhance ATP starvation to lethal levels. In contrast, when cells are supplemented with high quantities of energy and resveratrol, the inhibition of OXPHOS might produce a low-energy environment, mimicking the beneficial effects of caloric restriction. This review suggests that investigating a possible complex relationship between caloric intake and the differential effects of resveratrol on OXPHOS may be justified. PRACTICAL APPLICATIONS: A low-calorie diet accompanied by significant levels of resveratrol might modify cellular bioenergetics, which could impact cellular viability and enhance the anti-cancer properties of resveratrol.

- `what_it_does`: one sentence (under 120 chars) describing the ingredient's primary role in a formulation.
- `summary_short`: 2–3 sentences (under 400 chars), readable by a non-expert, suitable for a decode result. Include the most useful single fact a user would want to know at a glance.
- `summary_long`: 3–6 paragraphs in Markdown. Cite at least one source by PMID inline using `[PMID:12345678]` notation. Cover: mechanism, evidence quality, typical concentrations if mentioned, irritation/safety notes, common pairings or conflicts.
- `quick_facts`: array of 3–6 consumer-useful short bullet strings (<80 chars each). Examples: "Water-soluble", "Best below 10% concentration", "Pairs poorly with vitamin C".

Constraints:
- Never invent claims. If the abstracts don't support a claim, omit it.
- Never assign an overall rating ("great", "bad", etc.) — that's reserved for human curators.
- If evidence is thin, say so plainly in `summary_long`.

Write for skincare consumers, not researchers. Avoid evidence-audit language such as “typical concentration not provided,” “the abstracts do not mention,” or “no specific conflicts were identified.” Only mention a limitation if it changes how a user should interpret safety, effectiveness, or product use. Otherwise, leave that detail out.

